(Reuters) - The European Medicines Agency said on Tuesday it has received an application for marketing authorization for Moderna (NASDAQ:MRNA) Inc's COVID-19 vaccine candidate.
(Reuters) - The European Medicines Agency said on Tuesday it has received an application for marketing authorization for Moderna (NASDAQ:MRNA) Inc's COVID-19 vaccine candidate.